Federal Trade Commission
Protecting America's Consumers
Skip to Main Content
Privacy Policy
Advanced Search
Old Search
En Español
Home
About the FTC
Commissioners
Offices & Bureaus
Inspector General
Jobs
FOIA
Budget & Performance
News
About Public Affairs
Public Events
Speeches
Testimony
Webcasts
Blogs
Reporter Resources
Noticias en Español
Competition
About BC
Premerger Notification
Enforcement
Guidance
Advocacy Filings
En Español
Consumer Protection
About BCP
Consumer Information
Business Information
Resources
File a Complaint
Protección del Consumidor en Español
Economics
About BE
Research
Events
Presentations
Educational Materials
Economía en Español
General Counsel
FOIA
Policy Studies
Amicus Briefs
Legal Authority
Statutes
About the Office of General Counsel
Actions
Rules
Documents
Cases (by name)
All Actions (by date)
About the Office of the Secretary
Congressional
Newsletter
Senate/House Links
Appropriations
Testimony
About Congressional Relations
Policy
Reports
Advocacy Filings
About Policy Planning
International
Technical Assistance
Foreign Authorities
Cooperation Agreements
Consumer Protection
Competition
About Intl. Affairs
In the Matter of Watson Pharmaceuticals, Inc., a corporation and Andrx Corporation, a corporation.
FTC File No. 061-1039
Docket No. C-4172
December 12, 2006
Decision and Order
[Public Record Version]
Order
to Maintain Assets
Letter
Approving Interim Monitor Agreement and Appointment of the Interim Monitor
Interim Monitor Agreement
[Public Record Version]
Complaint
News Release
October 31, 2006
Agreement
Containing Consent Orders
Decision and Order
[Public Record Version]
Complaint
Analysis
of Proposed Consent Order to aid Public Comment
Order
to Maintain Assets
Letter
Approving Interim Monitor
Interim Monitor Agreement
[Public Record Version]
News Release
Last Modified: Wednesday, 27-Jun-2007 16:11:00 EDT